ArticleScientific reports2026
Hypoxia-preconditioned gingiva-derived mesenchymal stem cell-conditioned medium accelerates burn wound healing.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Burn injuries remain a major clinical challenge due to the complex wound microenvironment and limited donor skin availability. Gingival mesenchymal stem cells (GMSCs), which are easily accessible and possess strong immunomodulatory and regenerative capacities, represent a promising therapeutic resource. Increasing attention has focused on the use of GMSC-derived conditioned medium (CM) as a cell-free alternative, particularly when its efficacy is enhanced through hypoxic preconditioning. In this study, human-derived GMSC-conditioned medium was used to examine the effects of hypoxia-preconditioned GMSC-CM (HP-GMSC-CM) on burn wound healing in vitro and in vivo. In HaCaT keratinocyte cultures, HP-GMSC-CM significantly promoted scratch wound closure and enhanced cell migration in Transwell assays, accompanied by upregulated expression of LAMC2 and COL4A1. In M1-polarized macrophages, HP-GMSC-CM markedly suppressed secretion of the pro-inflammatory cytokines TNF-α and IL-1β. In a murine burn model, treatment with HP-GMSC-CM accelerated wound closure and increased the expression of epithelial marker Pan-CK and extracellular matrix protein TNC. Mechanistic inhibition with LY294002 suggested that these therapeutic effects are mediated, at least in part, through PI3K/AKT-associated signaling. Collectively, these findings suggest that hypoxia-preconditioned GMSC-derived CM may serve as an effective cell-free therapeutic strategy for promoting burn wound repair and support its potential translational applicability despite the use of a xenogeneic experimental model.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.